A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
Clinical trial NCT02219477 · COMPLETED
Trial details
- NCT number
- NCT02219477
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-24
- Primary completion
- 2016-06-13
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.